Metraipolis › archive › dc_1cd4945166fd

Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42279426
DOI
10.3390/cancers18111844
License (as archived)
solo-consultazione
Archived
2026-10-31T17:55:30.692Z
SHA-256 of the archived text
9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209
Stable URL of this page
https://metraipolis.com/documento/dc_1cd4945166fd

How to cite

Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426 — Europe PMC (en), https://europepmc.org/article/MED/42279426 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1cd4945166fd (Metraipolis archive dc_1cd4945166fd, sha256 9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209)
BibTeX
@misc{dc1cd4945166fd,
  title = {Pan-RAS Inhibitors: Expanding Therapeutic Potential and Evading Resistance — Europe PMC PMID:42279426},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42279426},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1cd4945166fd; sha256 9727ca9734d1b665b041a14e0aef799125f3e4b7b954850138428a9a02858209},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279426. Agents can read the archived copy with the MCP tool read_document.